Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 263 of 5804
-
Heart valve fix without a surgery center? major trial tests safety
Disease control Recruiting nowTRACS-PRIME is a prospective, randomized, multicenter clinical trial evaluating whether transcatheter aortic valve implantation (TAVI) can be performed safely and effectively in selected hospitals without on-site cardiac surgery, when appropriate patient selection, experienced op…
Phase: NA • Sponsor: University Hospital of Ferrara • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
AI reads chest X-Rays in the ER to catch silent killers early
Diagnosis Recruiting nowSEARCH-ED is a research study which is running in Emergency Department (ED) of the Queen Elizabeth University Hospital. The aim of the study is to find out if using a computer programme can help doctors diagnose heart and lung problems from chest x-rays. We want to compare how m…
Phase: NA • Sponsor: NHS Greater Glasgow and Clyde • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Gene therapy injection targets Parkinson's in patients with GBA1 mutations
Disease control Not yet recruitingA Phase I/II Clinical Study to Evaluate the Tolerability, Safety, and Efficacy of VGN-R08b Intra-cerebroventricular injection in Parkinson's Disease Patients with GBA1 Mutations
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug could reduce Blood-Letting for polycythemia vera patients
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of sapablursen when added on to current standard of care (SOC) for Polycythemia Vera (PV) therapy. The study will be conducted in three sequential parts (Part 1a blinded treatment, Part 1b open-label treatment, \& P…
Phase: PHASE3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a simple STI test prevent preterm birth?
Prevention Recruiting nowThis study will evaluate whether routine screening and treatment for two common sexually transmitted infections, chlamydia and gonorrhoea, during pregnancy can reduce preterm birth and other poor birth outcomes in Botswana, and whether this approach is affordable and cost-effecti…
Phase: NA • Sponsor: Adriane Wynn • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Can a simple swab predict who needs less radiation?
Diagnosis Recruiting nowThis study focuses on the longitudinal monitoring of HPV infection in patients with head and neck cancers, particularly oropharyngeal carcinoma (OPC), using a new electrochemical detection method. This method has already been successfully developed and validated for cervical canc…
Phase: NA • Sponsor: Masaryk Memorial Cancer Institute • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
Herbal tablet aims to reverse liver scarring in fatty liver disease
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Fuzheng Huayu Tablets in patients with metabolic dysfunction-associated fatty liver cirrhosis (compensated). Eligible patients will be randomly assigned to re…
Phase: PHASE4 • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug duo targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis is an open-label, multicenter Phase II clinical study conducted in subjects with advanced breast cancer.
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Lupus drug trial aims for remission without daily pills
Disease control Recruiting nowThis study will assess how mosunetuzumab works in people who have systemic lupus erythematosus (SLE) who may or may not also have active lupus nephritis (LN).
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Freeze-and-Heat attack: could a new device boost liver cancer treatment?
Disease control Not yet recruitingMultimodal Thermal Therapy combined with targeted therapy and immunotherapy versus targeted therapy and immunotherapy alone for systemically untreated unresectable hepatocellular carcinoma (HCC)
Phase: NA • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Acupuncture with a jolt: could needles shield nerves from chemo?
Prevention Not yet recruitingThis randomized controlled clinical trial aims to clarify the clinical efficacy and safety of electroacupuncture combined with thumbtack needle for the prevention of chemotherapy-induced peripheral neuropathy(CIPN), and to provide high-level evidence-based medicine for the preven…
Phase: NA • Sponsor: Affiliated Hospital of Qinghai University • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New Immune-Boosting drug combo targets Hard-to-Treat cancers
Disease control Not yet recruitingThis study is researching a new drug called REGN15505 when used alone or in combination with cemiplimab or in combination with REGN4336 in adult patients with mCRPC and ccRCC. The goal is to explore new ways to treat these cancers by helping immune cells target and destroy cancer…
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Lupus patients may get new hope from In-Body cell therapy
Disease control Recruiting nowThis is a single-center, open-label, exploratory clinical study designed to evaluate the efficacy and safety of IASO207 Injection (in vivo CAR-T) in patients with active refractory systemic lupus erythematosus.
Phase: EARLY_PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New 24-Strain pneumonia vaccine enters human trials
⭐️ VACCINE ⭐️ Not yet recruitingThis clinical trial consists of Phase I and Phase II. The objective is to evaluate the safety and immunogenicity of the 24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/tetanus toxoid) in individuals aged 2 months (minimum 6 weeks) and older.
Phase: PHASE1, PHASE2 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:36 UTC
-
Magic mushroom therapy could ease PTSD in sexual assault survivors
Symptom relief Recruiting nowA Phase 2, Open-Label Study to explore the efficacy, safety, and tolerability of psilocybin-assisted therapy in women with sexual assault-related Posttraumatic Stress Disorder (PTSD).
Phase: PHASE2 • Sponsor: Sunstone Medical • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New hope for ulcerative colitis: experimental drug JNJ-78934804 enters final testing phase
Disease control Recruiting nowThe purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining o…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could licorice root make CAR-T cancer therapy safer and stronger?
Disease control Not yet recruitingThe purpose of this study is to evaluate the effect of oral diammonium glycyrrhizinate in reducing toxicity and enhancing efficacy of CAR-T cell therapy in patients with large B-cell lymphoma. Two main questions are addressed: 1) Can oral diammonium glycyrrhizinate reduce the inc…
Phase: PHASE2, PHASE3 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug duo aims to control two cancers at once
Disease control Recruiting nowThe goal of this clinical trial is to learn if teclistamab in combination with daratumumab (Tec-Dara) works to treat newly diagnosed multiple myeloma with concurrent light chain amyloidosis (MM+AL). It will also learn about the safety of this combination. The main questions it ai…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New combo therapy aims to stop pancreatic cancer return after surgery
Disease control Recruiting nowPancreatic cancer is a highly fatal malignant tumor. Simple surgical operations can no longer meet the treatment needs of pancreatic cancer patients. Postoperative adjuvant chemotherapy has a significant effect, which can effectively prevent or delay tumor recurrence and prolong …
Phase: PHASE3 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New Crohn's drug shows promise in major trial
Disease control Recruiting nowThe purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active Crohn's disease (a long-term, progressive \[worsens with time\] and life-threatening d…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC